It has been suggested that PPARγ ligands reduce the development of atherosclerosis and myocardial ischemia–reperfusion injury through inhibition of platelet activation and intra-arterial thrombus formation in animal models [38]. The gene discussed is PPARG; the disease is atherosclerosis.